Medicine and Dentistry
Patient
100%
Drug-Eluting Stent
54%
Percutaneous Coronary Intervention
35%
Stent
35%
Inpatient
32%
Therapeutic Procedure
32%
Myocardial Infarction
27%
Target Lesion Revascularization
25%
Follow up
22%
Heart Failure
21%
Metabolic Syndrome
19%
Brain Natriuretic Peptide
18%
Complication
17%
Acute Heart Infarction
17%
Odds Ratio
16%
Platelet Reactivity
16%
Stent Thrombosis
16%
ST Segment Elevation Myocardial Infarction
16%
Artery Disease
16%
Radial Artery
15%
Intravascular Ultrasound
15%
Combination Therapy
14%
Obesity
14%
Intima-Media Thickness
13%
Coronary Angiography
13%
Hazard Ratio
12%
Age
12%
Lesion
12%
Primary Percutaneous Coronary Intervention
11%
Heart Death
11%
Male
11%
Woman
11%
Incidence
11%
Bleeding
11%
Percutaneous Transluminal Angioplasty
10%
Cardiovascular Disease
10%
Mortality
10%
Thorax Injury
10%
Fractional Flow Reserve
10%
Systolic Blood Pressure
10%
Rapamycin
10%
Diabetes Mellitus
10%
Predictor
10%
Obstruction
10%
Association
10%
Metal
9%
Body Mass Index
9%
All Cause Mortality
9%
Coronary Artery Disease
9%
Propensity Score Matching
9%
Pharmacology, Toxicology and Pharmaceutical Science
Stent
21%
Heart Infarction
11%
Metabolic Syndrome X
10%
Heart Death
10%
Umirolimus
10%
Everolimus
8%
Rapamycin
8%
Heart Failure
6%
Amlodipine
6%
Cause of Death
6%
Anticoagulant Agent
5%
Zotarolimus
5%
Drug
5%
Losartan
5%
Adiponectin
5%
CYP2C19
5%
Disease
5%
Obesity
5%
ST Segment Elevation Myocardial Infarction
5%
Combination Therapy
5%
Peripheral Occlusive Artery Disease
5%
Takotsubo Cardiomyopathy
5%
Gamma Interferon
5%
Ticagrelor
5%
Artery Disease
5%
Statin (Protein)
5%
Coronary Artery Atherosclerosis
5%
Randomized Controlled Trial
5%
Systolic Heart Failure
5%
Low Density Lipoprotein Cholesterol
5%
Nursing and Health Professions
Patient
28%
Brain Natriuretic Peptide
13%
Follow up
10%
Systolic Blood Pressure
7%
Inpatient
7%
Percutaneous Coronary Intervention
7%
Procedures
7%
Heart Failure
7%
Cardiovascular Disease
7%
Amlodipine
6%
Drug Eluting Stent
5%
Stent
5%
Takotsubo Cardiomyopathy
5%
Metabolic Syndrome X
5%
Losartan
5%
Percutaneous Coronary Intervention
5%
Intravascular Ultrasound
5%
